Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriella Parma

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Management of ovarian stromal cell tumorsNicoletta Colombo, Gabriella Parma, Vanna Zanagnolo, et al.
Expert Review of Anticancer Therapy|September 25, 2015
Neoadjuvant chemotherapy in cervical cancer: an updateMariateresa Lapresa, Gabriella Parma, Rosalba Portuesi, et al.
Gynecologic Oncology|August 31, 2007
Chemo-conization in early cervical cancerFabio Landoni, Gabriella Parma, Michele Peiretti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 27, 2023
Myeloid neoplasms post PARP inhibitors for ovarian cancerGiuseppe Caruso, Federica Gigli, Gabriella Parma, et al.
Critical Reviews in Oncology/Hematology|October 5, 2006
Ovarian cancerNicoletta Colombo, Toon Van Gorp, Gabriella Parma, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 17, 2023
Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer: lessons learned and future directionsGiuseppe Caruso, Federica Tomao, Gabriella Parma, et al.
Gynecologic Oncology|September 13, 2011
Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experienceAndrea Maneo, Mario Sideri, Giovanni Scambia, et al.
Journal of the National Cancer Institute|January 11, 2011
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancerRobert Fruscio, Annalisa Garbi, Gabriella Parma, et al.
The Oncologist|May 8, 2024
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysisLuca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancerNicoletta Colombo, Franca Formelli, Maria Grazia Cantù, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2007
Management of ovarian stromal cell tumorsNicoletta Colombo, Gabriella Parma, Vanna Zanagnolo, et al.
Expert Review of Anticancer Therapy|September 25, 2015
Neoadjuvant chemotherapy in cervical cancer: an updateMariateresa Lapresa, Gabriella Parma, Rosalba Portuesi, et al.
Gynecologic Oncology|August 31, 2007
Chemo-conization in early cervical cancerFabio Landoni, Gabriella Parma, Michele Peiretti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 27, 2023
Myeloid neoplasms post PARP inhibitors for ovarian cancerGiuseppe Caruso, Federica Gigli, Gabriella Parma, et al.
Critical Reviews in Oncology/Hematology|October 5, 2006
Ovarian cancerNicoletta Colombo, Toon Van Gorp, Gabriella Parma, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 17, 2023
Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer: lessons learned and future directionsGiuseppe Caruso, Federica Tomao, Gabriella Parma, et al.
Gynecologic Oncology|September 13, 2011
Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experienceAndrea Maneo, Mario Sideri, Giovanni Scambia, et al.
Journal of the National Cancer Institute|January 11, 2011
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancerRobert Fruscio, Annalisa Garbi, Gabriella Parma, et al.
The Oncologist|May 8, 2024
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysisLuca Boscolo Bielo, Matteo Repetto, Edoardo Crimini, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancerNicoletta Colombo, Franca Formelli, Maria Grazia Cantù, et al.
Pageof 3